一个高度选择性的核糖核受体的逐步成型
Shin-ichi Sato1, Masatora Fukuda, Masaki Hagihara
1Institute of Advanced Energy, Kyoto University, Japan.
Journal of the American Chemical Society
|January 6, 2005
概括
本研究介绍了一种逐步成型技术,以创建具有增强ATP结合口袋的RNA- (RNP) 复合体. 这种方法提高了对ATP的亲和力和选择性,为设计人工受体和酶提供了一个多功能平台.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 合成生物学 合成生物学
背景情况:
- RNA- (RNP) 复合体具有结构特征,可用于联结口袋工程.
- 之前的工作证明了使用RRE RNA和Rev用于ATP结合的RNP复合物的成型.
研究的目的:
- 开发一种阶段性成型方法,以创建具有增强联体结合口袋的RNP复合体.
- 为了提高基于RNP的ATP受体的亲和力和特异性.
主要方法:
- 逐步进行RNA和子子单元的体外选择和成型.
- 使用随机残留物构建RNP库.
- 在一个与两个步骤中成型的ATP结合口袋的比较分析.
主要成果:
- 对RNA和子单元的顺序成型产生了一个ATP结合口袋,对ATP的亲和力和特异性高于dATP.
- 两步成型过程通过结合RNA和成分来增强ATP识别表面.
- 这种方法通过整合不同生物聚合物的特征来扩大RNP库的多样性.
结论:
- 逐步塑造RNP复合体是一种有效的策略,用于生成具有增强亲和力和选择性的人工受体.
- 基于多个子单元的核蛋白方法可以适应创建具有多种化学活动的新生物宏分子组件.
相关概念视频
Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


